Ben-Noon Alon 13D and 13G filings for NeuroSense Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 10:14 am Purchase | 2023-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN | Ben-Noon Alon | 3,072,600 19.980% | 36,000 (+1.19%) | Filing |
| 2023-04-05 08:02 am Purchase | 2022-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN | Ben-Noon Alon | 3,036,600 25.770% | 36,000 (+1.20%) | Filing |
| 2021-12-23 5:03 pm Purchase | 2021-12-13 | 13G | NeuroSense Therapeutics Ltd. NRSN | Ben-Noon Alon | 3,000,600 27.420% | 3,000,600 (New Position) | Filing |